Reply

Ann Neurol. 2017 Oct;82(4):647-648. doi: 10.1002/ana.25039. Epub 2017 Oct 4.

Authors

Nicolas Fissolo¹, Béatrice Pignolet², David Brassat², Manuel Comabella¹

Affiliations

¹ Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
² Pole des Neurosciences Centre Hospitalier Universitaire Toulouse, CPTP INSERM UMR 1043 et Université de Toulouse, UPS, France.

PMID: 28869673
DOI: 10.1002/ana.25039

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Leukoencephalopathy, Progressive Multifocal*
Matrix Metalloproteinase 9
Multiple Sclerosis*
Natalizumab

Substances

Natalizumab
Matrix Metalloproteinase 9